Welcome to eBioscience   Tel: 888.999.1371 or 858.642.2058
Fax: 858.642.2046
Web: www.ebioscience.com
E-mail: info@ebioscience.com

Product Information


Contents: Phycoerythrin (PE) anti-human DR3 (TRAMP, Apo-3, TRAIL Receptor family)
Catalog Number: 12-6603
Sizes: 25 tests, 100 tests
Formulation: Phosphate buffer pH 7.2,
150 mM NaCl, 0.09% NaN3, 0.2% BSA
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
LIGHT-SENSITIVE MATERIAL.
Clone: JD3
Isotype: Mouse IgG1, κ
 
 
data image 1
Surface staining of human TRAMP transfected cells with anti-human DR3 (JD3) PE. Appropriate isotype controls were used (open histogram). Total viable cells were used for analysis. 

Available Formats of This Product
Cat. No. Format Excite
(nm)
Emit
(nm)
Reported Applications
12-6603 PE anti-human DR3 (TRAMP, Apo-3, TRAIL Receptor family) 488 575 FC 
13-6603 Biotin anti-human DR3 (TRAMP, Apo-3, TRAIL Receptor family) N/A N/A FC 
14-6603 Affinity Purified anti-human DR3 (TRAMP, Apo-3, TRAIL Receptor family) N/A N/A FC 

Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq.

Description


The JD3 monoclonal antibody reacts with human DR3, also known as Apo-3, WSL-1, TRAMP, LARD, DDR3, and TR3. DR3, a novel death receptor is expressed at low level by monocytes and granulocytes. Interaction of DR3 with its ligand activates NF-κB pathway and induces apoptosis. Initially, DR3 was thought to be a receptor for TWEAK, but further studies have shown that TWEAK could induce apoptosis via receptors distinct from DR3. JD3 has been reported for use in flow cytometric analysis.


Applications Reported


For research use only, not for diagnostic or therapeutic use. The JD3 antibody has been reported for use in flow cytometric analysis.


Applications Tested


The JD3 antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral leukocytes and human DR3-transfected cells. This can be used at 20 μl per 100 μl blood (or per 1 million cells in 100 μl total staining volume).


References



Nakayama, M., K. Ishidoh, et al. 2002. Multiple pathways of TWEAK-induced cell death. J Immunol 168(2): 734-43.
Nakayama, M., N. Kayagaki, et al. (2000). "Involvement of TWEAK in Interferon {gamma}-stimulated Monocyte Cytotoxicity." J. Exp. Med. 192(9): 1373-1380.


Related Products


Cat. 12-4714    Phycoerythrin (PE) Mouse IgG1, K Isotype Control



Copyright © 2000-2008 eBioscience, Inc.
Product For Research Use Only: Not for further distribution without written consent.